Single particle analysis of tau oligomer formation induced by metal ions and organic solvents

Biochemical and Biophysical Research Communications

Volumn 411, Issue 1, 2011, Pages 190-196

  Bader, Benedikt ^a,b   Nübling, Georg ^a,b   Mehle, Anja ^a   Nobile, Simona ^a   Kretzschmar, Hans ^a   Giese, Armin ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Alpha synuclein; Alzheimer; Dementia; Fluorescence correlation spectroscopy; Neurodegeneration; Oligomer; Tau

Indexed keywords

ALUMINUM; COPPER ION; DETERGENT; DIMETHYL SULFOXIDE; FERRIC ION; MAGNESIUM ION; MANGANESE; METAL ION; OLIGOMER; ORGANIC SOLVENT; TAU PROTEIN; ZINC ION;

ANALYTIC METHOD; ARTICLE; CONCENTRATION RESPONSE; FLUORESCENCE CORRELATION SPECTROSCOPY; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; REACTION ANALYSIS;

CATIONS, DIVALENT; DIMETHYL SULFOXIDE; HUMANS; METALS; MICROSCOPY, ATOMIC FORCE; SOLVENTS; TAU PROTEINS;

EID: 79960556315     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.06.135     Document Type: Article

References (33)

1. Galpern W.R., Lang A.E. Interface between tauopathies and synucleinopathies: a tale of two proteins. Ann. Neurol. 2006, 59:449-458.
2. Mackenzie I.R., Neumann M., Bigio E.H., Cairns N.J., Alafuzoff I., Kril J., Kovacs G.G., Ghetti B., Halliday G., Holm I.E., Ince P.G., Kamphorst W., Revesz T., Rozemuller A.J., Kumar-Singh S., Akiyama H., Baborie A., Spina S., Dickson D.W., Trojanowski J.Q., Mann D.M. Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta Neuropathol. 2010, 119:1-4.
3. Braak H., Alafuzoff I., Arzberger T., Kretzschmar H.A., Del Tredici K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol. 2006, 112:389-404.
4. Wittmann C.W., Wszolek M.F., Shulman J.M., Salvaterra P.M., Lewis J., Hutton M., Feany M.B. Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles. Science 2001, 293:711-714.
5. Santacruz K., Lewis J., Spires T., Paulson J., Kotilinek L., Ingelsson M., Guimaraes A., DeTure M., Ramsden M., McGowan E., Forster C., Yue M., Orne J., Janus C., Mariash A., Kuskowski M., Hyman B., Hutton M., Ashe K.H. Tau suppression in a neurodegenerative mouse model improves memory function. Science 2005, 309:476-481.
6. Yoshiyama Y., Higuchi M., Zhang B., Huang S.M., Iwata N., Saido T.C., Maeda J., Suhara T., Trojanowski J.Q., Lee V.M. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 2007, 53:337-351.
7. Wille H., Drewes G., Biernat J., Mandelkow E.M., Mandelkow E. Alzheimer-like paired helical filaments and antiparallel dimers formed from microtubule-associated protein tau in vitro. J. Cell Biol. 1992, 118:573-584.
8. King M.E., Gamblin T.C., Kuret J., Binder L.I. Differential assembly of human tau isoforms in the presence of arachidonic acid. J. Neurochem. 2000, 74:1749-1757.
9. Barghorn S., Mandelkow E. Toward a unified scheme for the aggregation of tau into Alzheimer paired helical filaments. Biochemistry 2002, 41:14885-14896.
10. Chirita C.N., Necula M., Kuret J. Anionic micelles and vesicles induce tau fibrillization in vitro. J. Biol. Chem. 2003, 278:25644-25650.
11. Sahara N., Maeda S., Murayama M., Suzuki T., Dohmae N., Yen S.H., Takashima A. Assembly of two distinct dimers and higher-order oligomers from full-length tau. Eur. J. Neurosci. 2007, 25:3020-3029.
12. King M.E., Ahuja V., Binder L.I., Kuret J. Ligand-dependent tau filament formation: implications for Alzheimer's disease progression. Biochemistry 1999, 38:14851-14859.
13. Munishkina L.A., Phelan C., Uversky V.N., Fink A.L. Conformational behavior and aggregation of alpha-synuclein in organic solvents: modeling the effects of membranes. Biochemistry 2003, 42:2720-2730.
14. Gray E.G., Paula-Barbosa M., Roher A. Alzheimer's disease: paired helical filaments and cytomembranes. Neuropathol. Appl. Neurobiol. 1987, 13:91-110.
15. Bondareff W., Matsuyama S.S., Dell'Albani P. Production of paired helical filament, tau-like proteins by PC12 cells: a model of neurofibrillary degeneration. J. Neurosci. Res. 1998, 52:498-504.
16. Klatzo I., Wisniewski H., Streicher E. Experimental production of neurofibrillary degeneration. I. Light microscopic observations. J. Neuropathol. Exp. Neurol. 1965, 24:187-199.
17. Mizoroki T., Meshitsuka S., Maeda S., Murayama M., Sahara N., Takashima A. Aluminum induces tau aggregation in vitro but not in vivo. J. Alzheimers Dis. 2007, 11:419-427.
18. Krewski D., Yokel R.A., Nieboer E., Borchelt D., Cohen J., Harry J., Kacew S., Lindsay J., Mahfouz A.M., Rondeau V. Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide. J. Toxicol. Environ. Health B. Crit. Rev. 2007, 10(Suppl. 1):1-269.
19. Bieschke J., Giese A., Schulz-Schaeffer W., Zerr I., Poser S., Eigen M., Kretzschmar H.A. Ultrasensitive detection of pathological prion protein aggregates by dual-color scanning for intensely fluorescent targets. Proc. Natl. Acad. Sci. USA 2000, 97:5468-5473.
20. Kostka M., Hogen T., Danzer K.M., Levin J., Habeck M., Wirth A., Wagner R., Glabe C.G., Finger S., Heinzelmann U., Garidel P., Duan W., Ross C.A., Kretzschmar H.A., Giese A. Single particle characterization of iron-induced pore-forming alpha-synuclein oligomers. J. Biol. Chem. 2008, 283:10992-11003.
21. Giese A., Bader B., Bieschke J., Schaffar G., Odoy S., Kahle P.J., Haass C., Kretzschmar H. Single particle detection and characterization of synuclein co-aggregation. Biochem. Biophys. Res. Commun. 2005, 333:1202-1210.
22. Harper J.D., Lansbury P.T. Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu. Rev. Biochem. 1997, 66:385-407.
23. Hiraoka S., Yao T.M., Minoura K., Tomoo K., Sumida M., Taniguchi T., Ishida T. Conformational transition state is responsible for assembly of microtubule-binding domain of tau protein. Biochem. Biophys. Res. Commun. 2004, 315:659-663.
24. Minoura K., Mizushima F., Tokimasa M., Hiraoka S., Tomoo K., Sumida M., Taniguchi T., Ishida T. Structural evaluation of conformational transition state responsible for self-assembly of tau microtubule-binding domain. Biochem. Biophys. Res. Commun. 2005, 327:1100-1104.
25. Scott C.W., Fieles A., Sygowski L.A., Caputo C.B. Aggregation of tau protein by aluminum. Brain Res. 1993, 628:77-84.
26. Yamamoto A., Shin R.W., Hasegawa K., Naiki H., Sato H., Yoshimasu F., Kitamoto T. Iron (III) induces aggregation of hyperphosphorylated tau and its reduction to iron (II) reverses the aggregation: implications in the formation of neurofibrillary tangles of Alzheimer's disease. J. Neurochem. 2002, 82:1137-1147.
27. Levin J., Bertsch U., Kretzschmar H., Giese A. Single particle analysis of manganese-induced prion protein aggregates. Biochem. Biophys. Res. Commun. 2005, 329:1200-1207.
28. Otzen D. Protein-surfactant interactions: a tale of many tales. Biochim. Biophys. Acta 2011, 1814:562-591.
29. Li W., Ma K.K., Sun W., Paudel H.K. Phosphorylation sensitizes microtubule-associated protein tau to Al(3+)-induced aggregation. Neurochem. Res. 1998, 23:1467-1476.
30. McDermott J.R., Smith A.I., Iqbal K., Wisniewski H.M. Brain aluminum in aging and Alzheimer disease. Neurology 1979, 29:809-814.
31. Markesbery W.R., Ehmann W.D., Alauddin M., Hossain T.I. Brain trace element concentrations in aging. Neurobiol. Aging 1984, 5:19-28.
32. Andrasi E., Pali N., Molnar Z., Kosel S. Brain aluminum, magnesium and phosphorus contents of control and Alzheimer-diseased patients. J. Alzheimers Dis. 2005, 7:273-284.
33. Bertsch U., Winklhofer K.F., Hirschberger T., Bieschke J., Weber P., Hartl F.U., Tavan P., Tatzelt J., Kretzschmar H.A., Giese A. Systematic identification of antiprion drugs by high-throughput screening based on scanning for intensely fluorescent targets. J. Virol. 2005, 79:7785-7791.